CD8+ T cells mediate kidney fibrosis in diet-induced obese mice

Abstract

Diet-induced obesity (DIO) is an epidemic in the United States and globally. Obesity is well known to exacerbate and/or promote kidney disease. Inflammation is a major factor in DIO and kidney disease. Utilizing a 20-week DIO mouse model (45% fat) and a normal diet (ND; 10% fat), our lab previously showed greater kidney medullary interstitial fibrosis as well as increased kidney medullary CD3+ T cells in DIO mice when compared to ND mice. Specifically, we found increased kidney CD8+ T cells, but similar CD4+ T cells, in DIO mice compared to ND mice. We hypothesized that CD8+ T cells in DIO mice are a primary factor in promoting kidney interstitial fibrosis. DIO mice were treated with anti-CD8 antibody or control anti-IgG antibody and ND mice were treated with control anti-IgG antibody for the final two weeks of the DIO protocol (n=7-9). DIO/anti-IgG and DIO/anti-CD8 mice had significantly higher body weight than ND/anti-IgG mice as expected (one-way ANOVA; p<0.0001). Administration of anti-CD8 treatment in DIO mice had null effects on body weight (one-way ANOVA, p=0.509) and kidney weight (one-way ANOVA; p=0.067). Utilizing flow cytometry, we verified that anti-CD8 treatment significantly reduced CD8+ T cells compared to anti-IgG in the kidney (one-way ANOVA; p=0.0077; DIO/anti-IgG vs DIO/anti-CD8, p=0.0066) and in the blood (one-way ANOVA; p=0.0034; DIO/anti-IgG vs DIO/anti-CD8, p=0.0048). Using Picrosirius Red histological staining to assess kidney fibrosis, we found that anti-CD8 treatment significantly blunted kidney medullary fibrosis (one-way ANOVA, p=0.0177, ND/anti-IgG vs DIO/anti-IgG, p=0.0329; DIO/anti-IgG vs DIO/anti-CD8, p=0.0318), whereas glomerular fibrosis was not affected by anti-CD8 treatment in DIO mice (one-way ANOVA, p=0.31). Urine was collected in 12-hour increments and analyzed for markers of kidney damage. All groups of mice showed similar urinary KIM-1 excretion (one-way ANOVA; p=0.62) and protein excretion (one-way ANOVA; p=0.69). DIO mice with anti-CD8 or anti-IgG treatment had significantly increased urinary NGAL excretion compared to ND mice (one-way ANOVA; p=0.0203). In summary, anti-CD8 treatment reduced circulating and kidney CD8+ T cells, as well as kidney medullary interstitial fibrosis but not urinary NGAL excretion. These results indicate that CD8+ T cells mediate kidney medullary interstitial fibrosis in a 20 week DIO mouse model. Funding: R01 DK134562, R25 DK115353, F31HL167626. This is the full abstract presented at the American Physiology Summit 2024 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.